|
Re: Classifying/taxonomy mCRPC patients
|
4
|
Zenith Epigenetics
|
Apr 20, 2019 03:44PM
|
|
Re: CKD Reata / Market Cap
|
3
|
Resverlogix Corp.
|
May 03, 2019 10:33AM
|
|
Re: Brd4 Inflammation Psoriasis
|
|
Resverlogix Corp.
|
May 08, 2019 10:31AM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
1
|
Resverlogix Corp.
|
Mar 25, 2019 10:27AM
|
|
Re: Bio Europe presentation happening now
|
4
|
Resverlogix Corp.
|
Nov 06, 2018 01:21PM
|
|
Re: BETonMACE Placebo Estimate
|
1
|
Resverlogix Corp.
|
Feb 20, 2019 05:44PM
|
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 06:11PM
|
|
Re: BETonMACE Placebo Estimate
|
3
|
Resverlogix Corp.
|
Feb 20, 2019 09:53AM
|
|
Re: BET proteins, NFkB and Diabetic Kidney Disease
|
6
|
Resverlogix Corp.
|
Nov 05, 2018 04:48PM
|
|
Re: Beigene
|
1
|
Resverlogix Corp.
|
May 07, 2019 10:07AM
|
|
Re: Beigene
|
2
|
Resverlogix Corp.
|
May 07, 2019 12:30PM
|
|
Re: Arvinas /ARVN dBET vs iBET
|
2
|
Zenith Epigenetics
|
Oct 13, 2018 04:05PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin
|
3
|
Resverlogix Corp.
|
Dec 04, 2018 08:37PM
|
|
Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin
|
2
|
Resverlogix Corp.
|
Dec 04, 2018 09:19PM
|
|
Re: Anyone have $285000
|
1
|
Resverlogix Corp.
|
May 08, 2019 01:47PM
|
|
Re: Antibodies Against Microglial Receptors TREM2 and CD33 Head to Trials
|
6
|
Resverlogix Corp.
|
May 11, 2019 07:04AM
|
|
Re: Another Indication ?
|
1
|
Resverlogix Corp.
|
May 11, 2019 10:55AM
|
|
Re: Amarin CEO interview - New class action lawsuit
|
5
|
Resverlogix Corp.
|
Nov 14, 2018 08:13PM
|
|
Re: Amarin CEO interview
|
4
|
Resverlogix Corp.
|
Nov 12, 2018 02:35PM
|
|
Re: Amarin / Mineral Oil
|
4
|
Resverlogix Corp.
|
Nov 10, 2018 03:57PM
|
